Evidence map›Paper›PMID 26864208›Full record

ArticleScientific reports2016

Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing.

Chiara Bolognesi, Claudio Forcato, Genny Buson, Francesca Fontana, Chiara Mangano, Anna Doffini, Valeria Sero, Rossana Lanzellotto, Giulio Signorini, Alex Calanca and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. DEPArray™ system: An automatic image-based sorter for isolation of pure circulating tumor cells.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Chiara BolognesiSilicon Biosystems S.p.A, Bologna, Italy.
Claudio ForcatoSilicon Biosystems S.p.A, Bologna, Italy.
Genny BusonSilicon Biosystems S.p.A, Bologna, Italy.
Francesca FontanaSilicon Biosystems S.p.A, Bologna, Italy.
Chiara ManganoSilicon Biosystems S.p.A, Bologna, Italy.
Anna DoffiniSilicon Biosystems S.p.A, Bologna, Italy.
Valeria SeroSilicon Biosystems S.p.A, Bologna, Italy.
Rossana LanzellottoSilicon Biosystems S.p.A, Bologna, Italy.
Giulio SignoriniSilicon Biosystems S.p.A, Bologna, Italy.
Alex CalancaSilicon Biosystems S.p.A, Bologna, Italy.
Maximilian SergioSilicon Biosystems S.p.A, Bologna, Italy.
Rita RomanoSilicon Biosystems S.p.A, Bologna, Italy.
Stefano GianniSilicon Biosystems S.p.A, Bologna, Italy.
Gianni MedoroSilicon Biosystems S.p.A, Bologna, Italy.
Giuseppe GiorginiSilicon Biosystems S.p.A, Bologna, Italy.
Hans MorreauDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Massimo BarberisEuropean Institute of Oncology, Milan, Italy.
Willem E CorverDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Nicolò ManaresiSilicon Biosystems S.p.A, Bologna, Italy.
Leiden University Medical Center · NLEuropean Institute of Oncology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precision medicine in oncology requires an accurate characterization of a tumor molecular profile for patient stratification. Though targeted deep sequencing is an effective tool to detect the presence of somatic sequence variants, a significant number of patient specimens do not meet the requirements needed for routine clinical application. Analysis is hindered by contamination of normal cells and inherent tumor heterogeneity, compounded with challenges of dealing with minute amounts of tissue and DNA damages common in formalin-fixed paraffin-embedded (FFPE) specimens. Here we present an innovative workflow using DEPArray™ system, a microchip-based digital sorter to achieve 100%-pure, homogenous subpopulations of cells from FFPE samples. Cells are distinguished by fluorescently labeled antibodies and DNA content. The ability to address tumor heterogeneity enables unambiguous determination of true-positive sequence variants, loss-of-heterozygosity as well as copy number variants. The proposed strategy overcomes the inherent trade-offs made between sensitivity and specificity in detecting genetic variants from a mixed population, thus rescuing for analysis even the smaller clinical samples with low tumor cellularity.

Indexed as

High-Throughput Nucleotide SequencingCell SeparationDNA Copy Number VariationsFixativesFlow CytometryFormaldehydeGenetic VariationHumansMicroarray AnalysisMutationNeoplasmsParaffin EmbeddingSensitivity and SpecificitySequence Analysis, DNATissue FixationFixativesFormaldehyde

Identifiers

PMID26864208
PMCPMC4750064
OpenAlexW2441600953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.